Indeterminate genotypes of hepatitis C virus by the Abbott RealTime HCV Genotype II assay in Morocco. About eight cases resolved by a sequencing method.
Z Mesbahi,
H Kabbaj,
H Malki,
N Bouihat,
M Qrafli,
B Belefquih,
S Marcil,
Dominique CHALLINE,
Jean-Michel PAWLOTSKY,
Magali BOUVIER-ALIAS,
M Seffar,
J Med Virol. 01/08/2018;90(8) : 1352-1357 10.1002/jmv.25191 26/04/2018
Detection of numerous HIV-1/MO recombinants in France.
F De Oliveira,
P Cappy,
V Lemee,
A Moisan,
C Pronier,
L Bocket,
Magali BOUVIER-ALIAS,
ML Chaix,
E Gault,
O Morvan,
JD Poveda,
V Schneider,
M Wirden,
E Alessandri-Gradt,
T Mourez,
JC Plantier,
AIDS 19/06/2018;32(10) : 1289-1299 10.1097/QAD.0000000000001814.
Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen
S Raymond,
F Nicot,
C Pallier,
P Bellecave,
A Maillard,
MA Trabaud,
L Morand-Joubert,
A Rodallec,
C Amiel,
T Mourez,
L Bocket,
A Beby-Defaux,
Magali BOUVIER-ALIAS,
S Lambert-Niclot,
C Charpentier,
B Malve,
A Mirand,
J Dina,
H Le Guillou-Guillemette,
S Marque-Juillet,
A Signori-Schmuck,
F Barin,
A Si-Mohamed,
V Avettand Fenoel,
C Roussel,
V Calvez,
K Saune,
AG Marcelin,
Christophe RODRIGUEZ,
D Descamps,
J Izopet,
ANRS AC11 Resistance Study Group
Clin Infect Dis. 02/05/2018;66(10) : 1588-1594 10.1093/cid/cix1070.
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.
L Assoumou,
C Charpentier,
P Recordon-Pinson,
M Grude,
C Pallier,
L Morand-Joubert,
S Fafi-Kremer,
A Krivine,
B Montes,
V Ferre,
Magali BOUVIER-ALIAS,
JC Plantier,
J Izopet,
MA Trabaud,
S Yerly,
J Dufayard,
C Alloui,
L Courdavault,
H Le Guillou-Guillemette,
A Maillard,
C Amiel,
A Vabret,
C Roussel,
S Vallet,
J Guinard,
A Mirand,
A Beby-Defaux,
F Barin,
A Allardet-Servent,
R Ait-Namane,
M Wirden,
C Delaugerre,
V Calvez,
ML Chaix,
D Descamps,
S Reigadas,
j Antimicrob Chemother. 01/06/2017;72(6) : 1769-1773 10.1093/jac/dkx042.
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis
M Bourliere,
P Rabiega,
N Ganne-Carrie,
L Serfaty,
P Marcellin,
Y Barthe,
D Thabut,
D Guyader,
Christophe HEZODE,
M Picon,
X Causse,
V Leroy,
JP Bronowicki,
P Carrieri,
G Riachi,
I Rosa,
P Attali,
JM Molina,
Y Bacq,
A Tran,
JD Grange,
F Zoulim,
H Fontaine,
L Alric,
I Bertucci,
Magali BOUVIER-ALIAS,
F Carrat,
Lancet Gastroenterol Hepatol. 01/03/2017;2(3) : 177-188 10.1016/S2468-1253(16)30189-3 20/01/2017
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
J Bruder Costa,
T Dufeu-Duchesne,
V Leroy,
I Bertucci,
Magali BOUVIER-ALIAS,
N Pouget,
O Brevot-Lutton,
M Bourliere,
F Zoulim,
J Plumas,
C Aspord,
PLoS One. 27/06/2016;11(6) : e0158297 10.1371/journal.pone.0158297
Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir-containing regimen.
Christophe HEZODE,
Stephane CHEVALIEZ,
G Scoazec,
Alexandre SOULIER,
A Varaut,
Magali BOUVIER-ALIAS,
Isaac RUIZ,
F Roudot-Thoraval,
A Mallat,
Cyrille FERAY,
Jean-Michel PAWLOTSKY,
Hepatology 01/06/2016;63(6) : 1809-1816 10.1002/hep.28491 10/03/2016
Multicenter clinical evaluation of the new 3rd generation assay for detection of antibodies against hepatitis C virus on the VIDAS(®) system.
B Seigneres,
F Descamps,
R Croise,
V Barlet,
Magali BOUVIER-ALIAS,
Stephane CHEVALIEZ,
Jean-Michel PAWLOTSKY,
W Abdelhady,
M Rafik,
AM Avellon,
JM Echevarria,
M Hausmann,
JM Dugua,
J Clin Virol. 01/05/2016;78 : 20-26 10.1016/j.jcv.2016.03.001. 04/03/2016